Literature DB >> 7543119

Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.

N Cimolai1, C Trombley, A G Davidson, L T Wong.   

Abstract

One hundred and six specimens from 90 patients with cystic fibrosis were evaluated for the presence of Burkholderia cepacia using a current routine diagnostic protocol as well as a research protocol involving polymyxin B-MacConkey agar without crystal violet, PC agar, OFPVL agar, and a selective brain-heart infusion broth. Ten specimens from eight patients (8.9%) were positive by any method. The selective enrichment broth was the only medium that yielded B cepacia from all 10 positive samples, although the routine protocol was successful for eight of these. Transient carriage was identified in one patient. Epidemiological studies may be better served by the use of selective enrichment rather than selective solid media alone. Carrier status for B cepacia requires more strict definition if positive carrier status is to be accepted as having medical importance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543119      PMCID: PMC502631          DOI: 10.1136/jcp.48.5.488

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA.

Authors:  A H WAHBA; J H DARRELL
Journal:  J Gen Microbiol       Date:  1965-03

2.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

3.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

4.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Authors:  L A Carson; O C Tablan; L B Cusick; W R Jarvis; M S Favero; L A Bland
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

7.  Comparison of two selective media developed to isolate Pseudomonas cepacia from patients with cystic fibrosis.

Authors:  C Black-Payne; M B Lierl; J A Bocchini; B C Hilman; E D Rambin; R Silberman
Journal:  Diagn Microbiol Infect Dis       Date:  1987-04       Impact factor: 2.803

8.  Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Authors:  O C Tablan; W J Martone; C F Doershuk; R C Stern; M J Thomassen; J D Klinger; J W White; L A Carson; W R Jarvis
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

9.  Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.

Authors:  G I Snell; A de Hoyos; M Krajden; T Winton; J R Maurer
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

  10 in total
  7 in total

1.  Isolation of Burkholderia cepacia by enrichment.

Authors:  P G Flanagan; A Paull
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

2.  Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients.

Authors:  J Hyde; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

3.  Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection.

Authors:  E Berriatua; I Ziluaga; C Miguel-Virto; P Uribarren; R Juste; S Laevens; P Vandamme; J R Govan
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  False negative results in enzyme linked immunosorbent assays using synthetic HIV antigens.

Authors:  L McAlpine; J V Parry; D Shanson; P P Mortimer
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

5.  A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabolic genes in Burkholderia cepacia AC1100.

Authors:  A Hübner; W Hendrickson
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

6.  Comparison of Mast Burkholderia Cepacia, Ashdown + Gentamicin, and Burkholderia Pseudomallei Selective Agar for the Selective Growth of Burkholderia Spp.

Authors:  Carola Edler; Henri Derschum; Mirko Köhler; Heinrich Neubauer; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-01-09

7.  Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis.

Authors:  Emma C L Marrs; Audrey Perry; John D Perry
Journal:  Microorganisms       Date:  2021-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.